Colombia makes landmark decision to declare the HIV medicine dolutegravir of public interest, allowing the country to purchase or manufacture more affordable, generic versions of the HIV medicine BOGOTÁ/GENEVA, 4 October 2023- applauds the government of Colombia for declaring the HIV medicine dolutegravir of public interest. This important breakthrough in public health measures will allow the government to issue a compulsory license, breaking the monopoly, and making it much more affordable for the Colombian government to purchase or manufacture.

https://www.miragenews.com/colombias-new-decision-for-affordable-hiv-1097477/

#miragenews